Glutamic acid ameliorates estrogen deficiency-induced menopausal-like symptoms in ovariectomized mice

Nutrition Research

Volumn 35, Issue 9, 2015, Pages 774-783

  Han, Na Ra ^a   Kim, Hee Yun ^a   Yang, Woong Mo ^a   Jeong, Hyun Ja ^b   Kim, Hyung Min ^a  

^a Kyung Hee University   (South Korea)

^b Hoseo University   (South Korea)

Author keywords

Alkaline phosphatase; Estrogen receptor ; Estrogen response element; Extracellular signal regulated kinase phosphorylation; Glutamic acid; Microcomputed tomography

Indexed keywords

ALKALINE PHOSPHATASE; ESTROGEN RECEPTOR BETA; GLUTAMIC ACID; KI 67 ANTIGEN; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; ESTROGEN; ESTROGEN RECEPTOR;

ALKALINE PHOSPHATASE BLOOD LEVEL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MINERAL; CELL PROLIFERATION; CONTROLLED STUDY; DRUG ACTIVITY; ENZYME ACTIVITY; ESTROGEN ACTIVITY; ESTROGEN BLOOD LEVEL; ESTROGEN DEFICIENCY; ESTROGEN RESPONSIVE ELEMENT; FEMALE; HUMAN; HUMAN CELL; MENOPAUSAL SYNDROME; MICRO-COMPUTED TOMOGRAPHY; MOUSE; NONHUMAN; OSTEOBLAST; OSTEOGENIC ACTIVITY; POROSITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; TRABECULAR BONE; VAGINA ATROPHY; WEIGHT GAIN; ANIMAL; ATROPHY; BAGG ALBINO MOUSE; BLOOD; BONE; BONE DENSITY; DEFICIENCY; DRUG EFFECTS; MCF 7 CELL LINE; MENOPAUSE; METABOLISM; OBESITY; OSTEOPOROSIS, POSTMENOPAUSAL; OVARIECTOMY; VAGINA;

ALKALINE PHOSPHATASE; ANIMALS; ATROPHY; BONE AND BONES; BONE DENSITY; CELL PROLIFERATION; ESTROGENS; ESTROGENS, NON-STEROIDAL; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FEMALE; GLUTAMIC ACID; HUMANS; KI-67 ANTIGEN; MCF-7 CELLS; MENOPAUSE; MICE; MICE, INBRED BALB C; OBESITY; OSTEOBLASTS; OSTEOPOROSIS, POSTMENOPAUSAL; OVARIECTOMY; RECEPTORS, ESTROGEN; VAGINA; WEIGHT GAIN;

EID: 84940893071     PISSN: 02715317     EISSN: 18790739     Source Type: Journal    
DOI: 10.1016/j.nutres.2015.06.006     Document Type: Article

References (70)

1. Mpalaris V., Anagnostis P., Goulis D.G., Iakovou I. Complex association between body weight and fracture risk in postmenopausal women. Obes Rev 2015, 16:225-233.
2. Hall J.M., Couse J.F., Korach K.S. The multifaceted mechanisms of estradiol and estrogen receptor signaling. J Biol Chem 2001, 276:36869-36872.
3. Song L., Zhao J., Zhang X., Li H., Zhou Y. Icariin induces osteoblast proliferation, differentiation and mineralization through estrogen receptor-mediated ERK and JNK signal activation. Eur J Pharmacol 2013, 714:15-22.
4. Fahlén M., Fornander T., Johansson H., Johansson U., Rutqvist L.E., Wilking N., et al. Hormone replacement therapy after breast cancer: 10 year follow up of the Stockholm randomised trial. Eur J Cancer 2013, 49:52-59.
5. Nedrow A., Miller J., Walker M., Nygren P., Huffman L.H., Nelson H.D. Complementary and alternative therapies for the management of menopause-related symptoms: a systematic evidence review. Arch Intern Med 2006, 166:1453-1465.
6. Reeds P.J., Burrin D.G., Stoll B., Jahoor F. Intestinal glutamate metabolism. J Nutr 2000, 130:978S-982S.
7. Tuomikoski P., Ylikorkala O., Mikkola T.S. Plasma nitrite/nitrate levels in women with postmenopausal hot flushes. Climacteric 2012, 15:153-156.
8. Auro K., Joensuu A., Fischer K., Kettunen J., Salo P., Mattsson H., et al. A metabolic view on menopause and ageing. Nat Commun 2014, 5:4708.
9. Ediz L., Hiz O., Meral I., Alpayci M. Complex regional pain syndrome: a vitamin K dependent entity?. Med Hypotheses 2010, 75:319-323.
10. Nilsen J., Brinton R.D. Impact of progestins on estradiol potentiation of the glutamate calcium response. Neuroreport 2002, 13:825-830.
11. Takuma K., Mizoguchi H., Funatsu Y., Kitahara Y., Ibi D., Kamei H., et al. Placental extract improves hippocampal neuronal loss and fear memory impairment resulting from chronic restraint stress in ovariectomized mice. J Pharmacol Sci 2012, 120:89-97.
12. Han N.R., Kim K.Y., Kim M.J., Kim M.H., Kim H.M., Jeong H.J. Porcine placenta mitigates protein-energy malnutrition-induced fatigue. Nutrition 2013, 29:1381-1387.
13. Giguère V., Tremblay A., Tremblay G.B. Estrogen receptor beta: re-evaluation of estrogen and antiestrogen signaling. Steroids 1998, 63:335-339.
14. Greger J.G., Guo Y., Henderson R., Ross J.F., Cheskis B.J. Characterization of MNAR expression. Steroids 2006, 71:317-322.
15. Al-Zaubai N., Johnstone C.N., Leong M.M., Li J., Rizzacasa M., Stewart A.G. Resolvin D2 supports MCF-7 cell proliferation via activation of estrogen receptor. J Pharmacol Exp Ther 2014, 351:172-180.
16. Prins H.J., Braat A.K., Gawlitta D., Dhert W.J., Egan D.A., Tijssen-Slump E., et al. In vitro induction of alkaline phosphatase levels predicts in vivo bone forming capacity of human bone marrow stromal cells. Stem Cell Res 2014, 12:428-440.
17. Kasperk C., Wergedal J., Strong D., Farley J., Wangerin K., Gropp H., et al. Human bone cell phenotypes differ depending on their skeletal site of origin. J Clin Endocrinol Metab 1995, 80:2511-2517.
18. Kanaya N., Chen S. Conjugated linoleic acid reduces body weight gain in ovariectomized female C57BL/6J mice. Nutr Res 2010, 30:714-721.
19. Yang L.C., Wu J.B., Ho G.H., Yang S.C., Huang Y.P., Lin W.C. Effects of poly-gamma-glutamic acid on calcium absorption in rats. Biosci Biotechnol Biochem 2008, 72:3084-3090.
20. Rucci N., Rufo A., Alamanou M., Capulli M., Del Fattore A., Ahrman E., et al. The glycosaminoglycan-binding domain of PRELP acts as a cell type-specific NF-kappaB inhibitor that impairs osteoclastogenesis. J Cell Biol 2009, 187:669-683.
21. Takao T., Kumagai C., Hisakawa N., Matsumoto R., Hashimoto K. Effect of 17beta-estradiol on tumor necrosis factor-alpha-induced cytotoxicity in the human peripheral T lymphocytes. J Endocrinol 2005, 184:191-197.
22. Hsieh C.Y., Santell R.C., Haslam S.Z., Helferich W.G. Estrogenic effects of genistein on the growth of estrogen receptor-positive human breast cancer (MCF-7) cells in vitro and in vivo. Cancer Res 1998, 58:3833-3838.
23. Chanawong A., Hu D.G., Meech R., Mackenzie P.I., McKinnon R.A. Induction of UDP-glucuronosyltransferase 2B15 gene expression by the major active metabolites of tamoxifen, 4-hydroxytamoxifen and endoxifen, in breast cancer cells. Drug Metab Dispos 2015, 43:889-897.
24. Park S.B., Lee Y.J., Chung C.K. Bone mineral density changes after ovariectomy in rats as an osteopenic model: stepwise description of double dorso-lateral approach. J Korean Neurosurg Soc 2010, 48:309-312.
25. Hong G.E., Pyun C.W., Jeong S.M., Han K.H., Lee C.H. Effects of fermented Pueraria radix by Lactobacillus acidophilus on lipid and bone metabolism in ovariectomized rats. Asian J Anim Vet Adv 2014, 9:556-567.
26. Lee E.J., Kim J.L., Kim Y.H., Kang M.K., Gong J.H., Kang Y.H. Phloretin promotes osteoclast apoptosis in murine macrophages and inhibits estrogen deficiency-induced osteoporosis in mice. Phytomedicine 2014, 21:1208-1215.
27. Yener T., Turkkani Tunc A., Aslan H., Aytan H., Cantug Caliskan A. Determination of oestrous cycle of the rats by direct examination: how reliable?. Anat Histol Embryol 2007, 36:75-77.
28. Kim M.H., Jeong H., Park M., Moon P.D. Effect of KH-BaRoKer-SeongJangTang based on traditional medicine theory on longitudinal bone growth. TANG 2014, 4:e14.
29. Bouxsein M.L., Boyd S.K., Christiansen B.A., Guldberg R.E., Jepsen K.J., Müller R. Guidelines for assessment of bone microstructure in rodents using micro-computed tomography. J Bone Miner Res 2010, 25:1468-1486.
30. Hu X.J., Xie M.Y., Kluxen F.M., Diel P. Genistein modulates the anti-tumor activity of cisplatin in MCF-7 breast and HT-29 colon cancer cells. Arch Toxicol 2014, 88:625-635.
31. Ariazi E.A., Clark G.M., Mertz J.E. Estrogen-related receptor alpha and estrogen-related receptor gamma associate with unfavorable and favorable biomarkers, respectively, in human breast cancer. Cancer Res 2002, 62:6510-6518.
32. Kato M., Takaishi H., Yoda M., Tohmonda T., Takito J., Fujita N., et al. GRIP1 enhances estrogen receptor alpha-dependent extracellular matrix gene expression in chondrogenic cells. Osteoarthritis Cartilage 2010, 18:934-941.
33. Han N.R., Oh H.A., Nam S.Y., Moon P.D., Kim D.W., Kim H.M., et al. TSLP induces mast cell development and aggravates allergic reactions through the activation of MDM2 and STAT6. J Invest Dermatol 2014, 134:2521-2530.
34. Camporez J.P., Jornayvaz F.R., Lee H.Y., Kanda S., Guigni B.A., Kahn M., et al. Cellular mechanism by which estradiol protects female ovariectomized mice from high-fat diet-induced hepatic and muscle insulin resistance. Endocrinology 2013, 154:1021-1028.
35. Sabry L., Abdul-Sattar M., Amin H.A., Abdel-Sattar E. Antiosteoporotic effect of some herbal extracts versus alendronate on an animal model of osteoporosis. Life Sci J 2013, 10:177-187.
36. Qu N., Wang L., Liu Z.C., Tian Q., Zhang Q. Oestrogen receptor α agonist improved long-term ovariectomy-induced spatial cognition deficit in young rats. Int J Neuropsychopharmacol 2013, 16:1071-1082.
37. Basha M.E., Chang S., Burrows L.J., Lassmann J., Wein A.J., Moreland R.S., et al. Effect of estrogen on molecular and functional characteristics of the rodent vaginal muscularis. J Sex Med 2013, 10:1219-1230.
38. Balakrishnan B., Chiplunkar S.V., Indap M.M. Methanol extract of Euchelus asper prevents bone resorption in ovariectomised mice model. J Osteoporos 2014, 2014:348189.
39. Kameda Y., Takahata M., Mikuni S., Shimizu T., Hamano H., Angata T., et al. Siglec-15 is a potential therapeutic target for postmenopausal osteoporosis. Bone 2015, 71:217-226.
40. Ali M.R., Zaidan T.F., Gorial F.I. Validity of osteocalcin and alkaline phosphatase biomarkers in postmenopausal women with low bone mineral density. Chem Mater Res 2014, 6:13-19.
41. Amato P., Christophe S., Mellon P.L. Estrogenic activity of herbs commonly used as remedies for menopausal symptoms. Menopause 2002, 9:145-150.
42. Chen J., Liu L., Hou R., Shao Z., Wu Y., Chen X., et al. Calycosin promotes proliferation of estrogen receptor-positive cells via estrogen receptors and ERK1/2 activation in vitro and in vivo. Cancer Lett 2011, 308:144-151.
43. Helle J., Kräker K., Bader M.I., Keiler A.M., Zierau O., Vollmer G., et al. Assessment of the proliferative capacity of the flavanones 8-prenylnaringenin, 6-(1.1-dimethylallyl)naringenin and naringenin in MCF-7 cells and the rat mammary gland. Mol Cell Endocrinol 2014, 392:125-135.
44. Kee N., Sivalingam S., Boonstra R., Wojtowicz J.M. The utility of Ki-67 and BrdU as proliferative markers of adult neurogenesis. J Neurosci Methods 2002, 115:97-105.
45. Gao Q.G., Xie J.X., Wong M.S., Chen W.F. IGF-I receptor signaling pathway is involved in the neuroprotective effect of genistein in the neuroblastoma SK-N-SH cells. Eur J Pharmacol 2012, 677:39-46.
46. Civitelli R., Villareal D.T., Agnusdei D., Nardi P., Avioli L.V., Gennari C. Dietary L-lysine and calcium metabolism in humans. Nutrition 1992, 8:400-405.
47. Lee C.G., Carr M.C., Murdoch S.J., Mitchell E., Woods N.F., Wener M.H., et al. Adipokines, inflammation, and visceral adiposity across the menopausal transition: a prospective study. J Clin Endocrinol Metab 2009, 94:1104-1110.
48. Matsubara M., Sakata I., Wada R., Yamazaki M., Inoue K., Sakai T. Estrogen modulates ghrelin expression in the female rat stomach. Peptides 2004, 25:289-297.
49. Lizcano F., Guzmán G. Estrogen deficiency and the origin of obesity during menopause. Biomed Res Int 2014, 2014:757461.
50. Archer D.F., Carr B.R., Pinkerton J.V., Taylor H.S., Constantine G.D. Effects of ospemifene on the female reproductive and urinary tracts: translation from preclinical models into clinical evidence. Menopause 2015, 22:786-796.
51. Pastore L.M., Carter R.A., Hulka B.S., Wells E. Self-reported urogenital symptoms in postmenopausal women: Women's Health Initiative. Maturitas 2004, 49:292-303.
52. Le Donne M., Caruso C., Mancuso A., Costa G., Iemmo R., Pizzimenti G., et al. The effect of vaginally administered genistein in comparison with hyaluronic acid on atrophic epithelium in postmenopause. Arch Gynecol Obstet 2011, 283:1319-1323.
53. Henriques H.N., de Carvalho A.C., Soares Filho P.J., Pantaleão J.A., Guzmán-Silva M.A. Effect of prolonged use of high dose of tibolone on the vagina of ovariectomized rats. Int J Exp Pathol 2011, 92:266-271.
54. Jaroenporn S., Urasopon N., Watanabe G., Malaivijitnond S. Improvements of vaginal atrophy without systemic side effects after topical application of Pueraria mirifica, a phytoestrogen-rich herb, in postmenopausal cynomolgus macaques. J Reprod Dev 2014, 60:238-245.
55. Xu Y., Ding J., Ma X.P., Ma Y.H., Liu Z.Q., Lin N. Treatment with Panax ginseng antagonizes the estrogen decline in ovariectomized mice. Int J Mol Sci 2014, 15:7827-7840.
56. Modder U.I., Riggs B.L., Spelsberg T.C., Fraser D.G., Atkinson E.J., Arnold R., et al. Dose-response of estrogen on bone versus the uterus in ovariectomized mice. Eur J Endocrinol 2004, 151:503-510.
57. Zhou H., Shen V., Dempster D.W., Lindsay R. Continuous parathyroid hormone and estrogen administration increases vertebral cancellous bone volume and cortical width in the estrogen-deficient rat. J Bone Miner Res 2001, 16:1300-1307.
58. Roman-Blas J.A., Castañeda S., Largo R., Herrero-Beaumont G. Osteoarthritis associated with estrogen deficiency. Arthritis Res Ther 2009, 11:241.
59. Uyar Y., Koltan S.O., Pögün S., Vatansever S., Caglar H. The effect of clomiphene citrate on osteoporosis in ovariectomized rats. Arch Gynecol Obstet 2008, 278:107-114.
60. Abdallah H.M., Al-Abd A.M., Asaad G.F., Abdel-Naim A.B., El-halawany A.M. Isolation of antiosteoporotic compounds from seeds of Sophora japonica. PLoS One 2014, 9:e98559.
61. Zhou Y., Mohan A., Moore D.C., Lin L., Zhou F.L., Cao J., et al. SHP2 regulates osteoclastogenesis by promoting preosteoclast fusion. FASEB J 2015, 29:1635-1645.
62. Wang X., He Y., Guo B., Tsang M.C., Tu F., Dai Y., et al. In vivo screening for anti-osteoporotic fraction from extract of herbal formula xianlinggubao in ovariectomized mice. PLoS One 2015, 10:e0118184.
63. Zhao Y.Y., Guo L., Zhao X.J., Liu H., Lei T., Ma D.J., et al. Transcriptional activation of insulin-like growth factor binding protein 6 by 17beta-estradiol in SaOS-2 cells. Exp Mol Med 2009, 41:478-486.
64. Galea G.L., Meakin L.B., Sugiyama T., Zebda N., Sunters A., Taipaleenmaki H., et al. Estrogen receptor α mediates proliferation of osteoblastic cells stimulated by estrogen and mechanical strain, but their acute down-regulation of the Wnt antagonist Sost is mediated by estrogen receptor β. J Biol Chem 2013, 288:9035-9048.
65. Kasperk C., Wergedal J., Strong D., Farley J., Wangerin K., Gropp H., et al. Human bone cell phenotypes differ depending on their skeletal site of origin. J Clin Endocrinol Metab 1995, 8:2511-2517.
66. Prouillet C., Mazière J.C., Mazière C., Wattel A., Brazier M., Kamel S. Stimulatory effect of naturally occurring flavonols quercetin and kaempferol on alkaline phosphatase activity in MG-63 human osteoblasts through ERK and estrogen receptor pathway. Biochem Pharmacol 2004, 67:1307-1313.
67. Luo X.H., Liao E.Y. Effects of estriol on the proliferation and differentiation of human osteoblastic MG-63 cells. Endocr Res 2003, 29:343-351.
68. Tang X., Zhu X., Liu S., Nicholson R.C., Ni X. Phytoestrogens induce differential estrogen receptor beta-mediated responses in transfected MG-63 cells. Endocrine 2008, 34:29-35.
69. Sundar S.N., Marconett C.N., Doan V.B., Willoughby J.A., Firestone G.L. Artemisinin selectively decreases functional levels of estrogen receptor-alpha and ablates estrogen-induced proliferation in human breast cancer cells. Carcinogenesis 2008, 29:2252-2258.
70. An J., Tzagarakis-Foster C., Scharschmidt T.C., Lomri N., Leitman D.C. Estrogen receptor beta-selective transcriptional activity and recruitment of coregulators by phytoestrogens. J Biol Chem 2001, 276:17808-17814.